Low heme oxygenase-1 levels in patients with systemic sclerosis are associated with an altered Toll-like receptor response: Another role for CXCL4?

Rheumatology (United Kingdom)

Volumn 55, Issue 11, 2016, Pages 2066-2073

  van Bon, Lenny ^a,b   Cossu, Marta ^a   Scharstuhl, Alwin ^b   Pennings, Bas W C ^b   Vonk, Madelon C ^b   Vreman, Hendrik J ^c   Lafyatis, Robert L ^d   van den Berg, Wim ^b   Wagener, Frank A D T G ^b   Radstake, Timothy R D J ^a,d,e  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Heme oxygenase 1; Platelet factor 4 CXCL4; Systemic sclerosis; Toll like receptors

Indexed keywords

BILIRUBIN; HEME OXYGENASE 1; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 6; LIGAND; PROTOPORPHYRIN COBALT; THROMBOCYTE FACTOR 4; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TUMOR NECROSIS FACTOR; CARBON MONOXIDE; CYTOKINE; TOLL LIKE RECEPTOR;

ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; DENDRITIC CELL; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; MICROARRAY KIT; MIDDLE AGED; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SUPERNATANT; SYSTEMIC SCLEROSIS; UPREGULATION; WESTERN BLOTTING; CASE CONTROL STUDY; DEFICIENCY; ENZYMOLOGY; FIBROBLAST; METABOLISM; MONONUCLEAR CELL; PHYSIOLOGY;

ADULT; BILIRUBIN; CARBON MONOXIDE; CASE-CONTROL STUDIES; CYTOKINES; DENDRITIC CELLS; FEMALE; FIBROBLASTS; HEME OXYGENASE-1; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; PLATELET FACTOR 4; SCLERODERMA, SYSTEMIC; TOLL-LIKE RECEPTORS;

EID: 84997080387     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kew251     Document Type: Article

References (34)

1. Distler O, Distler JH, Scheid A et al. Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosis. Circ Res 2004;95:109-16.
2. Silverstein JL, Steen VD, Medsger TA Jr, Falanga V. Cutaneous hypoxia in patients with systemic sclerosis (scleroderma). Arch Dermatol 1988;124:1379-82.
3. Stein CM, Tanner SB, Awad JA, Roberts LJ II, Morrow JD. Evidence of free radical-mediated injury (isoprostane overproduction) in scleroderma. Arthritis Rheum 1996;39:1146-50.
4. Tenhunen R, Marver HS, Schmid R. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Natl Acad Sci U S A 1968;61:748-55.
5. Ollinger R, Bilban M, Erat A et al. Bilirubin: a natural inhibitor of vascular smooth muscle cell proliferation. Circulation 2005;112:1030-9.
6. Brouard S, Otterbein LE, Anrather J et al. Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J Exp Med 2000;192:1015-26.
7. Lundvig DM, Immenschuh S, Wagener FA. Heme oxygenase, inflammation, and fibrosis: the good, the bad, and the ugly? Front Pharmacol 2012;3:81.
8. Yachie A, Niida Y, Wada T et al. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest 1999;103:129-35.
9. Kobayashi H, Takeno M, Saito T et al. Regulatory role of heme oxygenase 1 in inflammation of rheumatoid arthritis. Arthritis Rheum 2006;54:1132-42.
10. Wagener FA, Toonen EJ, Wigman L et al. HMOX1 promoter polymorphism modulates the relationship between disease activity and joint damage in rheumatoid arthritis. Arthritis Rheum 2008;58:3388-93.
11. Takeda Y, Takeno M, Iwasaki M et al. Chemical induction of HO-1 suppresses lupus nephritis by reducing local iNOS expression and synthesis of anti-dsDNA antibody. Clin Exp Immunol 2004;138:237-44.
12. Herrada AA, Llanos C, Mackern-Oberti JP et al. Haem oxygenase 1 expression is altered in monocytes from patients with systemic lupus erythematosus. Immunology 2012;136:414-24.
13. Tsuburai T, Suzuki M, Nagashima Y et al. Adenovirusmediated transfer and overexpression of heme oxygenase 1 cDNA in lung prevents bleomycin-induced pulmonary fibrosis via a Fas-Fas ligand-independent pathway. Hum Gene Ther 2002;13:1945-60.
14. Yet SF, Perrella MA, Layne MD et al. Hypoxia induces severe right ventricular dilatation and infarction in heme oxygenase-1 null mice. J Clin Invest 1999;103:R23-9.
15. Assassi S, Mayes MD, Arnett FC et al. Systemic sclerosis and lupus: points in an interferon-mediated continuum. Arthritis Rheum 2010;62:589-98.
16. Christmann RB, Sampaio-Barros P, Stifano G, et al. Association of Interferon-and transforming growth factor b-regulated genes and macrophage activation with systemic sclerosis-related progressive lung fibrosis. Arthritis Rheum 2014;66:714-25.
17. Farina G, Lafyatis D, Lemaire R, Lafyatis R. A four-gene biomarker predicts skin disease in patients with diffuse cutaneous systemic sclerosis. Arthritis Rheum 2010;62:580-8.
18. van Bon L, Popa C, Huijbens R et al. Distinct evolution of TLR-mediated dendritic cell cytokine secretion in patients with limited and diffuse cutaneous systemic sclerosis. Ann Rheum Dis 2010;69:1539-47.
19. Farina GA, York MR, Di Marzio M et al. Poly(I:C) drives type I IFN-and TGFb-mediated inflammation and dermal fibrosis simulating altered gene expression in systemic sclerosis. J Invest Dermatol 2010;130:2583-93.
20. van Bon L, Affandi AJ, Broen J et al. Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis. N Engl J Med 2014;370:433-43.
21. Gleissner CA, Shaked I, Erbel C et al. CXCL4 downregulates the atheroprotective hemoglobin receptor CD163 in human macrophages. Circ Res 2010;106:203-11.
22. Datta D, Banerjee P, Gasser M, Waaga-Gasser AM, Pal S. CXCR3-B can mediate growth-inhibitory signals in human renal cancer cells by down-regulating the expression of heme oxygenase-1. J Biol Chem 2010;285:36842-8.
23. van den Hoogen F, Khanna D, Fransen J et al. classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum 2013;65:2737-47.
24. LeRoy EC, Black C, Fleischmajer R et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5.
25. Vonk MC, Broers B, Heijdra YF et al. Systemic sclerosis and its pulmonary complications in The Netherlands: an epidemiological study. Ann Rheum Dis 2009;68:961-5.
26. McCarty MF. Serum bilirubin may serve as a marker for increased heme oxygenase activity and inducibility in tissues-a rationale for the versatile health protection associated with elevated plasma bilirubin. Med Hypotheses 2013;81:607-10.
27. Okuhara K, Kisaka T, Ozono R et al. Change in bilirubin level following acute myocardial infarction is an index for heme oxygenase activation. South Med J 2010;103:876-81.
28. Gajdócsy R, Horváth I. Exhaled carbon monoxide in airway diseases: from research findings to clinical relevance. J Breath Res 2010;4:047102.
29. Scharstuhl A, Mutsaers HA, Pennings SW et al. Curcumininduced fibroblast apoptosis and in vitro wound contraction are regulated by antioxidants and heme oxygenase: implications for scar formation. J Cell Mol Med 2009;13:712-25.
30. Barak M, Oron T, Mimouni FB, Dollberg S, Littner Y. Effect of hematocrit on exhaled carbon monoxide in healthy newborn infants. J Perinatol 2005;25:784-7.
31. Hsu E, Shi H, Jordan RM et al. Lung tissues in patients with systemic sclerosis have gene expression patterns unique to pulmonary fibrosis and pulmonary hypertension. Arthritis Rheum 2011;63:783-94.
32. Pilewski JM, Liu L, Henry AC, Knauer AV, Feghali-Bostwick CA. Insulin-like growth factor binding proteins 3 and 5 are overexpressed in idiopathic pulmonary fibrosis and contribute to extracellular matrix deposition. Am J Pathol 2005;166:399-407.
33. van Loon RL, Bartelds B, Wagener FA et al. Erythropoietin attenuates pulmonary vascular remodeling in experimental pulmonary arterial hypertension through interplay between endothelial progenitor cells and heme oxygenase. Front Pediatr 2015;3:71.
34. Tourkina E, Gooz P, Oates JC et al. Curcumin-induced apoptosis in scleroderma lung fibroblasts: role of protein kinase C". Am J Respir Cell Mol Biol 2004;31:28-35.